Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : InvestRight - Short Term Trading St -- Ignore unavailable to you. Want to Upgrade?

To: Gerald F Bunch who wrote (29)	9/6/1998 11:02:00 AM
From: Jeffrey L. Henken	Respond to of 939

Hi Gerald. First off let me say I do agree with your ex brother in law. However I am a bit of a contrarian. I believe that anything that looks too good probably is and visa versa. So we could take the bullish point of view on any stock and tear it down or do the complete reverse and do just fine depending on the stock's price. Looking at CCSI I would have to say that what makes it attractive to me is that a stock with an FDA approved product is now trading for 1/4 of it's yearly high. Obviously even that price is not justified if a deal on the Colormate III device is never made. Personally I think it's going to still happen but as I said before a rumored deal is not a deal. Time will tell. So for now it would still be reasonable to assume that the stock will be traded somewhere between 2 3/8's and 5. The possibility of doubling your money a couple of times before any deal is announced(I believe it will be) still exists but it's up to each investor to determine if they want to undertake that risk. That's why I included some phone numbers for people to call if they want to get more information. On ABMI I think the shorter term future of that company will be determined by what all they end up doing with LaSalle. Keep in mind that the company has some other outstanding technologies and 26 patents. Their product portfolio could eventually address a larger span of markets than any other company in the minimally invasive surgical field. They have also been looking for a strategic partner for a long time and if LaSalle does what I hope they will they might yet find one. On CLCK, well, we are overdue for some good news. The closure of BestBank has not resulted in any loss of business but it sure did not look good. The latest press release promised the announcement of the signing of any new contracts. I am certain that there will be lots of good news soon on CLCK so I'll be sharing my insight here on CLCK in depth soon. Oh one other thing. Medical professionals and dentists in particular are notoriously bad investors. I've made my share of mistakes and I've tried to learn form them. One thing is certain I will make more. InvestRight Do your own due diligence. The internet is full of information and phoning companies for information is always the next step. Regards, Jeff

To: Gerald F Bunch who wrote (29)	9/6/1998 2:25:00 PM
From: Peter V	Respond to of 939

Gerald, I believe that there is an expression amongst brokers for a questionable stock that they foist upon their wealthy yet unsophisticated customers, called "a doctor stock." Doctors have a lot of money, but often don't have a good handle on the market, and let their brokers do their trading for them. It's a generalization to be sure, but there is usually a grain of truth in most generalizations . . . To all would-be CCSI investors, best to look at both sides of the story before you invest.